Matsumura Y - Search Results

1

Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats.

Matsumura Y, Kuro T, Kobayashi Y, Umekawa K, Ohashi N, Takaoka M. Matsumura Y, et al. Jpn J Pharmacol. 2000 Sep;84(1):16-24. doi: 10.1254/jjp.84.16. Jpn J Pharmacol. 2000. PMID: 11043448 Free article.

2

Different contributions of the endothelin ET(A) receptor to hypertension induced by acute or chronic inhibition of nitric oxide synthesis.

Hashimoto N, Kuro T, Taira S, Matsumura Y. Hashimoto N, et al. Among authors: matsumura y. J Pharm Pharmacol. 1998 Sep;50(9):1051-8. doi: 10.1111/j.2042-7158.1998.tb06921.x. J Pharm Pharmacol. 1998. PMID: 9811167

3

Protective effect of KB-R7943, a novel Na+/Ca2+ exchange inhibitor, on ischemic acute renal failure in rats.

Kuro T, Kobayashi Y, Takaoka M, Matsumura Y. Kuro T, et al. Among authors: matsumura y. Jpn J Pharmacol. 1999 Oct;81(2):247-51. doi: 10.1254/jjp.81.247. Jpn J Pharmacol. 1999. PMID: 10591486 Free article.

4

Proteasome participates in the pathogenesis of ischemic acute renal failure in rats.

Takaoka M, Itoh M, Hayashi S, Kuro T, Matsumura Y. Takaoka M, et al. Among authors: matsumura y. Eur J Pharmacol. 1999 Nov 12;384(1):43-6. doi: 10.1016/s0014-2999(99)00664-0. Eur J Pharmacol. 1999. PMID: 10611418

5

Enhanced blood pressure sensitivity to DOCA-salt treatment in endothelin ET(B) receptor-deficient rats.

Matsumura Y, Kuro T, Konishi F, Takaoka M, Gariepy CE, Yanagisawa M. Matsumura Y, et al. Br J Pharmacol. 2000 Mar;129(6):1060-2. doi: 10.1038/sj.bjp.0703157. Br J Pharmacol. 2000. PMID: 10725252 Free PMC article.

6

Selective antagonism of the ETA receptor, but not the ETB receptor, is protective against ischemic acute renal failure in rats.

Kuro T, Kohnou K, Kobayashi Y, Takaoka M, Opgenorth TJ, Wessale JL, Matsumura Y. Kuro T, et al. Among authors: matsumura y. Jpn J Pharmacol. 2000 Apr;82(4):307-16. doi: 10.1254/jjp.82.307. Jpn J Pharmacol. 2000. PMID: 10875750 Free article.

7

Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.

Kuro T, Okahara A, Nose M, Ikuse T, Matsumura Y. Kuro T, et al. Among authors: matsumura y. Biol Pharm Bull. 2000 Jul;23(7):820-5. doi: 10.1248/bpb.23.820. Biol Pharm Bull. 2000. PMID: 10919359 Free article.

8

Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme.

Umekawa K, Hasegawa H, Tsutsumi Y, Sato K, Matsumura Y, Ohashi N. Umekawa K, et al. Among authors: matsumura y. Jpn J Pharmacol. 2000 Sep;84(1):7-15. doi: 10.1254/jjp.84.7. Jpn J Pharmacol. 2000. PMID: 11043447 Free article.

9

Increased susceptibility to deoxycorticosterone acetate-salt-induced hypertension in endothelin-B-receptor-deficient rats.

Matsumura Y, Kuro T, Kobayashi Y, Konishi F, Takaoka M, Wessale JL, Opgenorth TJ, Gariepy CE, Yanagisawa M. Matsumura Y, et al. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S86-9. doi: 10.1097/00005344-200036051-00028. J Cardiovasc Pharmacol. 2000. PMID: 11078344

10

Proteasome inhibition attenuates renal endothelin-1 production and the development of ischemic acute renal failure in rats.

Takaoka M, Itoh M, Kohyama S, Shibata A, Ohkita M, Matsumura Y. Takaoka M, et al. Among authors: matsumura y. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S225-7. doi: 10.1097/00005344-200036051-00067. J Cardiovasc Pharmacol. 2000. PMID: 11078383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,474 results

Search Page

Filters